Ambrisentan

Specifications

177036-94-1CAS Number

658-059-9EC Number

(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acidIUPAC Name

C22H22N2O4Chemical Formula

378.4 g/molMolecular Weight

Ambrisentan; 177036-94-1; Letairis; Volibris; LU-208075; BSF-208075; DTXSID4046282; HW6NV07QEC; GSK1325760A; GSK-1325760A; GSK1325760; GSK-1325760; DTXCID2026282; (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid; (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; (+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid; ambrisentanum; Pulmonext; (S)-ambrisentan; (+)-ambrisentan; (-)-ambrisentan; (2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; BSF208075; RefChem:56361; C02KX02; GSK 1325760A; GSK 1325760; 658-059-9; (S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid; (S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; BSF 208075; (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid; LU 208075; C22H22N2O4; MFCD09842330; CHEMBL1111; Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (alphaS)-; Ambrisentan [INN]; (s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid; CAS-177036-94-1; LU208075; UNII-HW6NV07QEC; Ambrisentan [INN:BAN:JAN]; Ambrisentan?; NCGC00160662-01; Letairis (TN); Volibris (TN); BSF 208075;LU 208075; Ambrisentan (Standard); Ambrisentan (JAN/INN); AMBRISENTAN [MI]; AMBRISENTAN [JAN]; AMBRISENTAN [VANDF]; SCHEMBL3679; A1D5J; AMBRISENTAN [MART.]; AMBRISENTAN [WHO-DD]; AMBRISENTAN, (+)-; MLS006010218; AMBRISENTAN [EMA EPAR]; GTPL3951; orb1225920; orb1307867; Ambrisentan - Bio-X trade mark; AMBRISENTAN [ORANGE BOOK]; CHEBI:135949; OUJTZYPIHDYQMC-LJQANCHMSA-N; GLXC-04478; EX-A3315; Tox21_111967; BDBM50146710; EBC-26858; FD7219; HY-13209R; s2097; AKOS015994540; Tox21_111967_1; AC-9015; CCG-268386; CS-0447; DB06403; DE-0223; FA17344; (?S)-?-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-?-methoxy-?-phenylbenzenepropanoic acid; NCGC00160662-02; NCGC00346730-01; NCGC00346730-06; BA164153; HY-13209; SMR004701307; A2966; SW219060-1; D07077; AB01566890_01; EN300-7368573; Q410789; BRD-K41185545-001-02-3; (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid; (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid; (S)-2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid; Ambrisentan2-(4,6-Dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid; Benzenepropanoic acid, |A-[(4,6-dimethyl-2-pyrimidinyl)oxy]-|A-methoxy-|A-phenyl-, (|AS)-; Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phenyl-, (.alpha.S)-Synonyms